Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Issues Quarterly Earnings Results

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) released its quarterly earnings results on Wednesday. The company reported $0.91 earnings per share for the quarter, Zacks reports. Recordati Industria Chimica E Farmaceutica had a return on equity of 34.38% and a net margin of 17.81%.

Recordati Industria Chimica E Farmaceutica Stock Performance

Shares of RCDTF remained flat at $58.00 during midday trading on Wednesday. Recordati Industria Chimica E Farmaceutica has a 1-year low of $55.88 and a 1-year high of $60.00. The company has a quick ratio of 0.86, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The company has a market cap of $11.97 billion, a P/E ratio of 21.94 and a beta of 0.25. The company has a 50-day simple moving average of $58.63 and a 200-day simple moving average of $59.46.

About Recordati Industria Chimica E Farmaceutica

Recordati Industria Chimica e Farmaceutica is an Italy‐based international pharmaceutical company engaged in the research, development, manufacturing and commercialization of therapeutic products. Established in 1926, the company has built a diversified portfolio that includes proprietary drugs, generics and orphan medicines, with a particular emphasis on treatments for rare diseases. Recordati’s product range spans cardiovascular, urology, endocrinology, dermatology and oncology therapies, as well as specialized formulations for genetic and metabolic disorders.

The company’s historical roots date back nearly a century, when it began as a family‐owned enterprise in Milan.